In 2014, the founders of Medical Marijuana Genetics first learnt of the therapeutic properties of the cannabis plant whilst desperately treating the symptoms of one of their mother’s late stage pancreatic cancer. Not long after her first dose of cannabis oil, she was able to move around relatively pain free, enabling her to tend to her beloved garden, in the weeks leading up to her death.
Through the organisation’s interaction with patients and cannabis communities worldwide, it quickly became apparent that access to cannabis genetics high in cannabinoids other than THC was severely limited. As a result of this, Medical Marijuana Genetics was formed with award winning breeders and caregivers from the Basque region of Spain, with the initial aim of creating a line of CBD dominant cannabis strains.
Candida (CD1) Feminised By Medical Marijuana Genetics
Candida (CD-1) has the highest CBD and lowest THC content of any strain currently available on the seed market. It was named after the founder of Medical Marijuana Genetics’ late mother and means ‘bright light’ in Latin.
Our Laboratory results show CBD levels of between 20.6% and 10.9% CBD with THC levels rising with higher CBD levels – but never passing 1% THC. The balance between CBD and THC remains more consistent than any similar strain.
- Feminised Strain
- Lab Tested Strains
- High CBD Content (20%+)
- Grows In Greenhouse
- Grows Outdoors
- Grows Indoors